300676 BGI Genomics
- 39.02
- +0.05+0.13%
BGI Genomics News
BGI Genomics: Announcement on plans for some directors and senior management to increase their shareholding in the company
BGI Genomics: An indicative announcement on the first grant of the second phase of the employee stock ownership plan and the expiration of the first lockdown period
BGI Genomics: Notice on cumulative litigation and arbitration
BGI Genomics: Announcement on the cancellation of some special fund-raising accounts
BGI Genomics: Notice on termination of product registration of wholly-owned subsidiaries
BGI Genomics: Announcement on the cancellation of some special fund-raising accounts
BGI Genomics: Legal Opinion of Guohao Law Firm (Shenzhen) on the 2023 Annual General Meeting of Shareholders of Shenzhen Huada Gene Co., Ltd.
BGI Genomics: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
BGI Genomics: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
BGI Genomics: Announcement of Resolutions of the 25th Meeting of the Third Board of Supervisors
BGI Genomics: Announcement on the 2022 Restricted Stock Incentive Plan for the first time granting some of the achievements of the first vesting period
BGI Genomics: Legal Opinion of Attorney Guo Hao (Shenzhen) Office on the First Grant of the 2022 Restricted Stock Incentive Plan of Shenzhen Huada Gene Co., Ltd., the fulfillment of the ownership conditions during the first vesting period and the abolition of some restricted stocks
BGI Genomics: Announcement on abolishing part of the 2022 Restricted Stock Incentive Plan and granting restricted stocks that have not yet been vested
BGI Genomics: Announcement of Resolutions of the 25th Meeting of the Third Board of Directors
BGI Genomics: 2024 First Quarter Report
BGI Genomics: Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. independent financial advisory report on matters relating to the first grant of part of the 2022 restricted stock incentive plan to Shenzhen Huada Gene Co., Ltd. for the first time
BGI Genomics: The Supervisory Board's Verification Opinions on the 2022 Restricted Stock Incentive Plan for the First Grant of a Part of the Vesting List for the First Vesting Period
BGI Genomics: CITIC Securities Co., Ltd. Summary Report on Continued Supervision and Sponsorship of the Issuance of Shares to Specific Targets by Shenzhen Huada Gene Co., Ltd.
BGI Genomics: CITIC Securities Co., Ltd. Summary Report on Continued Supervision and Sponsorship of the Issuance of Shares to Specific Targets by Shenzhen Huada Gene Co., Ltd.
BGI Genomics: CITIC Securities Co., Ltd.'s 2023 follow-up report on Shenzhen Huada Gene Co., Ltd.
Analysis
Price Target
No Data
